Larvol Delta - BrainStorm-Cell-Therapeutics-Reaches-Alignment-with-FDA-on-CMC-Aspects-of-Phase-3b-NurOwn-Clinical-Trial

NurOwn (MSC-NTF) - BrainStorm Cell Therap

https://www.prnewswire.com/news-releases/brainstorm-cell-therapeutics-reaches-alignment-with-fda-on-cmc-aspects-of-phase-3b-nurown-clinical-trial-302183061.html

Jun 26, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next